{"id":1613,"date":"2018-03-30T11:09:00","date_gmt":"2018-03-30T03:09:00","guid":{"rendered":"https:\/\/vcro.online\/?p=1613"},"modified":"2024-07-12T11:09:51","modified_gmt":"2024-07-12T03:09:51","slug":"congratulations-phase-i-cell-therapy-for-solid-tumor-clinical-study-report-was-granted-by-tfda","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1613","title":{"rendered":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!"},"content":{"rendered":"\n<p>Virginia Contract Research Organization Co., Ltd. (VCRO) has conducted and managed a Phase I cell therapy\u00a0\u00a0for\u00a0Solid Tumor\u00a0clinical trial with an array of services including clinical operation, data management, statistical analysis, CSR Writing, and GCP inspection preparation. The study was successfully completed and granted TFDA\u2019s approval on the clinical study report. This accomplishment has significantly paved the way for our client\u2019s new drug development journey.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Virginia Contract Research Organization Co., Ltd. (VCRO) has conducted and managed a Phase I cell therapy\u00a0\u00a0for\u00a0Solid Tumor\u00a0clinical trial with an array of services including clinical operation, data management, statistical analysis, CSR Writing, and GCP inspection preparation. The study was successfully completed and granted TFDA\u2019s approval on the clinical study report. This accomplishment has significantly paved [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1613","post","type-post","status-publish","format-standard","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1613\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1613\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2018-03-30T03:09:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-12T03:09:51+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\" \/>\r\n\t<meta property=\"og:image:width\" content=\"512\" \/>\r\n\t<meta property=\"og:image:height\" content=\"512\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!\",\"datePublished\":\"2018-03-30T03:09:00+00:00\",\"dateModified\":\"2024-07-12T03:09:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613\"},\"wordCount\":84,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1613\",\"name\":\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"datePublished\":\"2018-03-30T03:09:00+00:00\",\"dateModified\":\"2024-07-12T03:09:51+00:00\",\"description\":\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1613\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1613#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO","description":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1613","og_locale":"en_US","og_type":"article","og_title":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO","og_description":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1613","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2018-03-30T03:09:00+00:00","article_modified_time":"2024-07-12T03:09:51+00:00","og_image":[{"width":512,"height":512,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","type":"image\/png"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1613#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1613"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!","datePublished":"2018-03-30T03:09:00+00:00","dateModified":"2024-07-12T03:09:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1613"},"wordCount":84,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1613","url":"https:\/\/www.vcro.com.tw\/?p=1613","name":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"datePublished":"2018-03-30T03:09:00+00:00","dateModified":"2024-07-12T03:09:51+00:00","description":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA! VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1613#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1613"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1613#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1613"}],"version-history":[{"count":1,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1613\/revisions"}],"predecessor-version":[{"id":1614,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1613\/revisions\/1614"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}